# A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease

> **NCT01422187** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 19 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

- **DRUG:** Taliglucerase alfa

## Key facts

- **NCT ID:** NCT01422187
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422187, "A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01422187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*